Randall Rago

618 total citations
18 papers, 526 citations indexed

About

Randall Rago is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Randall Rago has authored 18 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Randall Rago's work include Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Randall Rago is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Randall Rago collaborates with scholars based in United States, Spain and Taiwan. Randall Rago's co-authors include George Wilding, William F. Henry, Maureen O. Ripple, Jacque Mitchen, Terry D. Oberley, Ann‐Lii Cheng, Susan Halabi, Paul R. Hutson, Nicholas J. Vogelzang and Dona Alberti and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Randall Rago

18 papers receiving 507 citations

Peers

Countries citing papers authored by Randall Rago

Since Specialization

Citations

This map shows the geographic impact of Randall Rago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Rago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Rago more than expected).

Fields of papers citing papers by Randall Rago

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Rago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Rago. The network helps show where Randall Rago may publish in the future.

Co-authorship network of co-authors of Randall Rago

This figure shows the co-authorship network connecting the top 25 collaborators of Randall Rago. A scholar is included among the top collaborators of Randall Rago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Rago. Randall Rago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Title	Journal	Authors	Indexed citations
1	Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer	Cancer Chemotherapy and Pharmacology	Randall Rago, Albert Einstein et al.	25
2	Higher doses of mitoxantrone among men with hormone‐refractory prostate carcinoma	Cancer	Ellis Levine, Susan Halabi et al.	14
3	Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480	Journal of Clinical Oncology	Eric J. Small, Susan Halabi et al.	44
4	Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice	Cancer Chemotherapy and Pharmacology	Dawn R. Church, Yunlei Zhang et al.	5
5	A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)	European Journal of Cancer	A Einstein, Richard M. Lush et al.	1
6	Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer	Cancer Control	Randall Rago	10
7	Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.	PubMed	Paul R. Hutson, Kendra D. Tutsch et al.	9
8	Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor.	Journal of Clinical Oncology	Jordan Berlin, K D Tutsch et al.	44
9	Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells	JNCI Journal of the National Cancer Institute	Maureen O. Ripple, George Wilding et al.	266
10	SSRIs in alcoholism: Fluvoxamine vs fluoxetine in alcoholic outpatients	Biological Psychiatry	Luigi Janiri, Randall Rago et al.	1
11	Use of a DNA microfluorometric assay to measure proliferative response of mink lung cells to purified TGFβ and to TGFβ activity found in prostate cell conditioned medium	In Vitro Cellular & Developmental Biology - Animal	Jacque Mitchen, Randall Rago et al.	5
12	P-10-21 Trazodone as a possible anticompulsive drug in alcoholism: A preliminary study in the post-detoxification period	European Neuropsychopharmacology	Luigi Janiri, Randall Rago et al.	1
13	Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans	Cancer	Randall Rago, Robert Sufit et al.	24
14	Evidence of an absorption phase after short intravenous suramin infusions	Cancer Chemotherapy and Pharmacology	Paul R. Hutson, Kendra D. Tutsch et al.	4
15	Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates	The Prostate	Jacque Mitchen, Randall Rago et al.	18
16	Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells.	PubMed	Randall Rago, Peter C. Brazy et al.	10
17	Two-dimensional poly(acrylamide) electrophoresis of fluoresceinated glycopeptides. Resolution and structural characterization of ovalbumin glycans	Carbohydrate Research	Randall Rago, R. D. Poretz et al.	9
18	Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.	PubMed	Randall Rago, Jacque Mitchen et al.	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact